We serve Chemical Name:3-Methyl-5-nitro-1H-pyrazole CAS:34334-96-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-Methyl-5-nitro-1H-pyrazole
CAS.NO:34334-96-8
Synonyms:5-methyl-3-nitropyrazole;3-nitro-5-methylpyrazole;1H-Pyrazole, 3-methyl-5-nitro-;5-Methyl-3-nitro-1H-pyrazole;3-Methyl-5-nitro-1H-pyrazole;5-Methyl-3-nitropyrazol;1H-Pyrazole, 5-methyl-3-nitro-
Molecular Formula:C4H5N3O2
Molecular Weight:127.101
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:335.7±22.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.592
PSA:74.50000
Exact Mass:127.038177
LogP:0.68
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-methyl-3-nitropyrazole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrazole, 5-methyl-3-nitro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrazole, 3-methyl-5-nitro- Use and application,5-Methyl-3-nitro-1H-pyrazole technical grade,usp/ep/jp grade.
Related News: In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. 3-Methyl-5-nitro-1H-pyrazole manufacturer he agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped. 3-Methyl-5-nitro-1H-pyrazole supplier The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 3-Methyl-5-nitro-1H-pyrazole vendor International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation. 3-Methyl-5-nitro-1H-pyrazole factory Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.
